ICON acquires market access consultancy
February 28, 2012Research and Development CRO, ICON, pharma market access, pricing and reimbursement
ICON has acquired consulting firm PriceSpective, helping to expand the contract research organisation’s services in the field of pricing and …
Doctors don’t want rationing responsibility, finds survey
February 28, 2012Sales and Marketing Commissioning Board, NHS, NHS reforms, NHSCB, NICE, rationing
A survey of GPs in England has found that most do not want powers to ration care for NHS patients.The …
Jon Linscott to head PAN Advertising
February 28, 2012Business Services, Medical Communications, Sales and Marketing Creston Health, Jon Linscott, Pan Advertising
Jon Linscott has been appointed managing director of PAN Advertising, a member of the Creston Health group of companies. Linscott …
GSK recalls Novartis’ blood pressure drug
February 28, 2012Manufacturing and Production DynaCirc CR, GSK, Novartis
GlaxoSmithKline is the latest company to be affected by manufacturing glitches at Novartis’ troubled facility in Lincoln, Nebraska, having been …
EMA confirms verdict on Ben Venue facility
February 28, 2012Manufacturing and Production Ben Venue, CHMP, EMA, Sanofi
The European Medicines Agency has officially removed Ben Venue Laboratories’ troubled Bedford facility as an approved location for the manufacture …
Shire’s Vpriv plant wins EU approval
February 28, 2012Manufacturing and Production EMA, Shire, Vpriv
Shire has been told by the European Medicines Agency that it can make use of a manufacturing facility in Lexington, …
Glivec cleared for longer use in GIST patients
February 28, 2012Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis
Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …
Lilly plans €330m biomanufacturing plant in Ireland
February 28, 2012Manufacturing and Production Abbott, Ireland, Kinsale, lilly
There was more good news for Ireland’s pharmaceutical sector this week with the announcement by Eli Lilly that it will …
Endo says Opana ER supply disruption will be temporary
February 28, 2012Manufacturing and Production Endo, Novartis, Opana ER
Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …
Priorclave Introduce Autoclave Application Selector at Arab Lab
February 27, 2012Manufacturing and Production
It is not unexpected to find that senior managers from British autoclave manufacturer Priorclave will be making their way East …
Witty hits out at ‘systematic delays’ to medicines
February 27, 2012Sales and Marketing Europe, GSK, NICE, austerity
GlaxoSmithKline’s chief executive says Europe’s drug budget cuts are undermining the industry and not addressing the biggest cost pressure in …
Janssen launches hep C support programme
February 27, 2012Medical Communications, Sales and Marketing BUPA, Copegas, Incivo, Janssen, Pegasys, hep C
Janssen has launched a hepatitis C support programme for patients in the UK to help with medicine adherence and healthy …
On-going Medicine evaluation Information to be published by European Medicines Agency
February 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), …
EMA accepts Genzyme MS drug for review
February 24, 2012Research and Development, Sales and Marketing EMA, Genzyme, Sanofi, teriflunomide
The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide. Genzyme, which is wholly owned by …
Werner Wenning proposed as chairman of the supervisory board at Bayer
February 24, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning
Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …
Care regulator chief steps down
February 24, 2012Sales and Marketing CQC, Cynthia Bower, Mid Staffs, reforms
The head of the Care Quality Commission Cynthia Bower has resigned from her post, amid growing pressure from the government. …
Genzyme to close UK site
February 24, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts
Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs. …
The NHS, a postcard from the frontline
February 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, Sussex, reforms
It is January 2012, and the NHS in England is under huge strain. This is because it is being asked …
Astellas hires senior vice president for new Global Medical Affairs organisation
February 24, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing
Astellas has announced that Charlotte Kremer has joined the company as the head of one of the Company’s newest organisations …
Changes to patient information in Europe
February 23, 2012Medical Communications, Sales and Marketing Commission, EC, ED, parliament
European authorities have made new proposals to allow pharma to communicate with patients and the public – but a ban …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
